>
Will China Retaliate Against Donald Trump's Oil Blockade and Force an American Surrender?
There can be no peace in the Middle East as long as the Zionist agenda of greater Israel rules
Elon Musk Reveals Covid Vaccine Injury After Former Pfizer Official Admits Shots Likely Killed...
Autonomous wing-in-ground effect aircraft has US military in its sights
The Most Dangerous Race on Earth Isn't Nuclear - It's Quantum.
This Plasma Stove Cooks Hotter Than The Sun
Energy storage breakthrough traps sunlight in a molecule
Steel rebar may have met its match – in the form of wavy plastic
Video: Semicircular wings give Cyclone VTOL a different kind of lift
After 20 Years, Wave Energy Finally Works
FCC Set To "Supercharge" Starlink Space Internet With "Seven-Fold More Capacity"
'World's First' Humanoid Robot For Real Household Chores Launched With 16-Hour Battery
XAI Training 10 Trillion Parameter Model – Likely Out in Mid 2026
Scientists from the Salk Institute say the safe and effective technique works by partially resetting cells that impact skin, eyesight, muscles, and the brain. The breakthrough may be able to extend life and help people gain the ability to become more resistant to stress, injury, and disease.
While it may appear to be the Holy Grail of anti-aging research, promising eternal youth, the team cautions that they've only successfully tested the treatment on mice so far. Animals at the late stage of their lives treated with cellular rejuvenation therapy started to show signs of getting younger after just seven months.
New tests are now underway to determine whether the treatment only "pauses" or actually reverses aging. In the study, the researchers note that all cells carry a molecular clock that records the passage of time. By adding a mixture of four reprogramming molecules, known as the Yamanaka factors, the cells reset the clock to their original patterns.
Turning back the clock in less than a year?
The scientists tested three groups of mice at varying ages equivalent to humans being 35, 50, and 80 years-old (12 months, 15 months, and 25 months in mice). There were no blood cell alterations or neurological changes in the mice that received the treatment. The team also found no cancers in any of the groups.